15(R)-15-Methyl Prostaglandin F2alpha Methyl Ester, with the CAS number 35700-22-2, is a synthetic analog of prostaglandin F2alpha, which is a naturally occurring lipid compound involved in various physiological processes. This compound is characterized by its structural modifications that enhance its stability and potency compared to its natural counterpart. It typically exhibits strong biological activity, particularly in the context of reproductive health, where it can influence uterine contractions and has applications in obstetrics and gynecology. The methyl ester form enhances its lipophilicity, facilitating better absorption and bioavailability. Additionally, it may have implications in the treatment of conditions such as glaucoma and in the induction of labor. As with many prostaglandins, it can also have side effects, including gastrointestinal disturbances and cardiovascular effects, necessitating careful consideration in therapeutic applications. Overall, 15(R)-15-Methyl Prostaglandin F2alpha Methyl Ester is a significant compound in pharmacology, particularly in reproductive medicine.

15(R)-
15-
methyl Prostaglandin F
2α
methyl ester (15(R)-
15-
methyl PGF
2α
methyl ester) is a lipid soluble prodrug form of 15(R)-
15-
methyl PGF
2α
with increased membrane permeability. Acid-
catalyzed epimerization of 15(R)-
15-
methyl PGF
2α
methyl ester and hydrolysis of the ester converts it into the active 15(S)-
15-
methyl PGF
2α
.
1
,
2

15(R)-15-METHYL PROSTAGLANDIN F2ALPHA METHYL ESTER

35700-22-2: 15(R)-15-Methyl Prostaglandin F2alpha Methyl Ester, with the CAS number 35700-22-2, is a synthetic analog of prostaglandin F2alpha, which is a naturally occurring lipid compound involved in various physiological processes. This compound is characterized by its structural modifications that enhance its stability and potency compared to its natural counterpart. It typically exhibits strong biological activity, particularly in the context of reproductive health, where it can influence uterine contractions and has applications in obstetrics and gynecology. The methyl ester form enhances its lipophilicity, facilitating better absorption and bioavailability. Additionally, it may have implications in the treatment of conditions such as glaucoma and in the induction of labor. As with many prostaglandins, it can also have side effects, including gastrointestinal disturbances and cardiovascular effects, necessitating careful consideration in therapeutic applications. Overall, 15(R)-15-Methyl Prostaglandin F2alpha Methyl Ester is a significant compound in pharmacology, particularly in reproductive medicine.

CAS 35700-22-2

15(R)-15-METHYL PROSTAGLANDIN F2ALPHA METHYL ESTER

Methyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-3-methyloct-1-en-1-yl)cyclopentyl)hept-5-enoate

Ref: ST-EA-CP-C65009